230 related articles for article (PubMed ID: 6395826)
1. Influence of some sulfhydryl compounds on the antineoplastic effectiveness of 5-fluorouracil and 6-mercaptopurine.
Danysz A; Wierzba K; Wutkiewicz M; Pniewska A; Pragłowski T; Burba-Anczewska I
Arch Immunol Ther Exp (Warsz); 1984; 32(3):345-9. PubMed ID: 6395826
[TBL] [Abstract][Full Text] [Related]
2. The effect of sulfhydryl compounds on 5-fluorouracil toxicity and distribution.
Danysz A; Wierzba K; Pniewska A; Kłosiewicz S; Burba-Anczewska I
Arch Immunol Ther Exp (Warsz); 1983; 31(3):373-9. PubMed ID: 6418114
[TBL] [Abstract][Full Text] [Related]
3. The effect of some sulfhydryl compounds on the toxicity of 5-fluorouracil and 6-mercaptopurine in laboratory animals.
Danysz A; Wierzba K; Wutkiewicz M; Pniewska A; Pragłowski T
Acta Pol Pharm; 1984; 41(5):571-4. PubMed ID: 6397972
[No Abstract] [Full Text] [Related]
4. Potentiation by vitamin A of the action of anticancer agents against murine tumors.
Nakagawa M; Yamaguchi T; Ueda H; Shiraishi N; Komiyama S; Akiyama S; Ogata J; Kuwano M
Jpn J Cancer Res; 1985 Sep; 76(9):887-94. PubMed ID: 3932288
[TBL] [Abstract][Full Text] [Related]
5. Antitumor activity of cyclocytidine in a variety of tumors.
Hoshi A; Kanzawa F; Kuretani K
Gan; 1972 Jun; 63(3):353-60. PubMed ID: 5072834
[No Abstract] [Full Text] [Related]
6. 6-Mercaptopurine-induced potentiation of active immunotherapy in L1210-bearing mice treated with concanavalin A-bound leukemia cell vaccine.
Kataoka T; Akahori Y; Sakurai Y
Cancer Res; 1984 Feb; 44(2):519-24. PubMed ID: 6537896
[TBL] [Abstract][Full Text] [Related]
7. [Effect of 4-methyluracil on the antineoplastic and toxic effect of 6-mercaptopurine].
Pol'kina RI
Vopr Onkol; 1971; 17(1):86. PubMed ID: 5108359
[No Abstract] [Full Text] [Related]
8. Sesquiterpene lactones XVII. Cytostatic and pharmacological activity.
Hladoń B; Chodera A
Arch Immunol Ther Exp (Warsz); 1975; 23(6):857-65. PubMed ID: 1220638
[TBL] [Abstract][Full Text] [Related]
9. [Antitumor chemotherapy. Considerations on the potential role of immunity].
Mihich E
Pathol Biol; 1967 Feb; 15(3):209-14. PubMed ID: 4860732
[No Abstract] [Full Text] [Related]
10. Characteristics and response to certain cancer chemotherapeutic agents of an acute lymphocytic leukemia arising in a BALB-c times DBA-2F1 mouse.
Yancey ST; Bleyer WA
Cancer Res; 1974 Aug; 34(8):1866-9. PubMed ID: 4526157
[No Abstract] [Full Text] [Related]
11. Combined therapy of L1210 leukemia with Damvar and cytostatics.
Pujman V; Cernochová S
Neoplasma; 1979; 26(5):521-3. PubMed ID: 522924
[TBL] [Abstract][Full Text] [Related]
12. Antitumor activity of N6-phenyladenosine, and inhibitor of adenosine utilization, in combination with related purine analogs.
Grindey GB; Divekar AY; Hakala MT
Cancer Res; 1973 Oct; 33(10):2459-63. PubMed ID: 4741936
[No Abstract] [Full Text] [Related]
13. Lack of activity of beta-2'-deoxythioguanosine against two tumors resistant to 6-thioguanine.
Nelson JA; Kuhns JN; Carpenter JW
Cancer Res; 1975 May; 35(5):1372-4. PubMed ID: 1168098
[No Abstract] [Full Text] [Related]
14. Enhancement of antileukemic effect in combination of 5-fluorouracil and OK-432.
Koshimura S; Ryoyama K
Cancer Treat Rep; 1977; 61(1):17-27. PubMed ID: 324619
[TBL] [Abstract][Full Text] [Related]
15. The synergistic anti-neoplastic activity of combinations of mitomycins with either 6-thioguanine or 5-fluorouracil.
Sartorelli AC; Booth BA
Cancer Res; 1965 Oct; 25(9):1393-400. PubMed ID: 5861069
[No Abstract] [Full Text] [Related]
16. [Time factor in evaluating antineoplastic agents].
Syrkin AB
Farmakol Toksikol; 1972; 35(1):75-9. PubMed ID: 5011523
[No Abstract] [Full Text] [Related]
17. The therapeutic effects of orally administered 5'-deoxy-5-fluorouridine, 1-(2-tetrahydrofuryl)-5-fluorouracil and 5-fluorouracil on experimental murine tumors.
Uehara N; Baba H; Nitta K; Kunimoto T; Takeuchi M; Sasaki T; Tanaka T
Jpn J Cancer Res; 1985 Oct; 76(10):1034-41. PubMed ID: 2934356
[TBL] [Abstract][Full Text] [Related]
18. Synergistic effects of bis(3-methylsulfonyloxypropyl)-amine toluenesulfonate (864-T) with 6-mercaptopurine and other antitumor agents.
Imamura H; Ikegami K; Okumoto T
Gan; 1973 Oct; 64(5):427-31. PubMed ID: 4358730
[No Abstract] [Full Text] [Related]
19. Inability of amphotericin B(Fungizone) or of sodium deoxycholate to alter natural drug resistance or sensitivity of transplanted murine leukemias.
Ganu UK; Khandalekar DD; Gokhale SV
Indian J Physiol Pharmacol; 1984; 28(1):21-6. PubMed ID: 6490126
[TBL] [Abstract][Full Text] [Related]
20. Anti leukemia activity (L1210) of 6-mercaptopurine and its metallo complexes in mice.
Skinner SM; Lewis RW
Res Commun Chem Pathol Pharmacol; 1977 Jan; 16(1):183-6. PubMed ID: 841179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
